Vbi Vaccines Inc buy stratec
Start price
10.11.17
/
50%
?3.72
Target price
23.10.18
€5.86
Performance (%)
-48.54%
End price
23.10.18
€1.91
Summary
This prediction ended on 23.10.18 with a price of €1.91. Massive losses of -48.54% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vbi Vaccines Inc | - | - | - | - |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% | 48.617% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% | 86.131% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% | 53.169% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% | 58.399% |
Comments by stratec for this prediction
In the thread Vbi Vaccines Inc diskutieren
stratec stimmt der Buy-Einschätzung von marge zu
stratec stimmt am 10.11.2017 der Buy-Einschätzung von marge mit dem Kursziel 6,5$ zu.Überschrift: VBIV continues making progress towards starting a Phase 3 trial for hepatitis B
(Laufzeit überschritten)